Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Tozinameran

Kikuchi-fujimoto disease in the axilla and injection site local pain

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Cho E, et al. Kikuchi-fujimoto Disease in the Axilla after COVID-19 Vaccination: A Case Report. Current medical imaging 20: 1-5, Jan 2023. Available from: URL: https://dx.doi.org/10.2174/1573405620666230620115956 Cho E, et al. Kikuchi-fujimoto Disease in the Axilla after COVID-19 Vaccination: A Case Report. Current medical imaging 20: 1-5, Jan 2023. Available from: URL: https://dx.doi.org/10.2174/1573405620666230620115956
Metadaten
Titel
Tozinameran
Kikuchi-fujimoto disease in the axilla and injection site local pain
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-52136-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Metformin

Case report

Tobramycin

Case report

Linaclotide